ENTITY
Kolon TissueGene

Kolon TissueGene (950160 KS)

16
Analysis
Health Care • United States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
more
bearish•Doosan Robotics
•30 Sep 2024 21:28

End of Mandatory Lock-Up Periods for 39 Companies in Korea in October 2024

We discuss the end of the mandatory lock-up periods for 39 stocks in Korea in October 2024, among which four are in KOSPI and 35 are in KOSDAQ.

Logo
696 Views
Share
•30 Apr 2024 17:05

End of Mandatory Lock-Up Periods for 54 Companies in Korea in May 2024

We discuss the end of the mandatory lock-up periods for 54 stocks in Korea in May 2024, among which 4 are in KOSPI and 50 are in KOSDAQ.

Logo
650 Views
Share
bullish•GigaVis
•11 Jan 2024 19:35

An Early Look at the Potential KOSDAQ150 Rebalance Candidates in June 2024

In this insight, we discuss the potential KOSDAQ150 rebalance candidates in June 2024. Potential inclusion candidates include LS Materials,...

Logo
490 Views
Share
•21 Dec 2017 08:14

StubWorld - Set-Up & Unwind Extremes: AVIC, Kolon

This week I briefly look at: Avic International Holdings Ltd (161 HK), again, as investors take-profit while 69.7%-held subsidiary Shennan Circuits...

Logo
702 Views
Share
bearish•CJ ENM
•10 Nov 2017 22:06

CJ E&M Vs. Hanjin Kal - Trade Pattern Analysis Amid Subsidiary IPO

We, Korea, have two major IPOs coming up late this year. They are Studio Dragon Corp (253450 KS) and Jin Air Co., Ltd. (272450 KS). Both are...

Logo
514 Views
Share
x